PLOS: DNA Science

APRIL 4, 2024

Among the barrage of drug ads for cancer, diabetes, weight loss and more are those for Lume , a “doctor-developed whole body deodorant.” ” The Patent Trail Rather than relying on social media, company websites, and testimonials, I consulted the Patent and Trademark database to reconstruct the story of invention.

Disease 65

Disease Testimonials Production FDA 65

Drug & Device Law

JULY 24, 2023

The drug is still on the market, and it has other risks that the FDA has found significantly more serious – requiring a boxed warning – than a three-one hundredths-of one-percent (0.0003) increase in absolute incidence of bladder cancer. 3d , 2023 WL 4191651 (C.D. PATDC82 II , 2023 WL 4191651, at *3. 2023 WL 4191651, at *8.

Testimonials 52

Testimonials Pharmacy FDA Doctors 52

Drug & Device Law

DECEMBER 29, 2023

In 2023 there seemed to be an unusually large number of other decisions that are likely to have a substantial impact on what we or our clients do, but involve either different products, non-product claims, or both. In 2023, these include United States ex rel. 2023) (no medical monitoring in Delaware) ( here ); Brown v.

Testimonials 105

Testimonials FDA Drugs Vaccine 105

Drug & Device Law

FEBRUARY 11, 2024

3d , 2023 WL 2825871 (N.D. April 7, 2023) (“ AHM I ”). 2023) (“ AHM II ”). Doctors Who Perform Abortions: Their Characteristics & Patterns of Holding & Using Hospital Privileges,” 6. See AHM I , 2023 WL 2825871, at *4 n.9 See AHM I , 2023 WL 2825871, at *4 n.9 FDA , 78 F.4th 4th 210 (5th Cir.

FDA 59

FDA Production FDA Approval Regulations 59

Drug & Device Law

APRIL 5, 2023

Illinois March 30, 2023), is a useful magistrate discovery ruling applying Rule 26’s limiting principle and granting a protective order against depositions of a defendant’s detail representatives. DePuy Orthopaedics, Inc. LEXIS 54471 (N.D. But those other cases are, well, other cases.

Testimonials 52

Testimonials Doctors Production Marketing 52

Drug & Device Law

OCTOBER 24, 2023

Defining “inconsistency” liberally, plaintiffs try to use sales reps to get around the learned intermediary doctrine often without much more evidence than that the sales rep visited the prescribing doctor. A step in the right direction of keeping the doctors in the foreground of the analysis. Depuy Orthopaedics, Inc. LEXIS 54471 (N.D.

Testimonials 59

Testimonials Doctors Production Treatment 59